CYCC Bio Green Med Solution Inc.


$ 2.86 $ -0.09 (-3.03 %)    

Tuesday, 21-Oct-2025 16:10:49 EDT
QQQ $ 610.40 nm (nm)
DIA $ 469.66 $ 2.20 (0.47 %)
SPY $ 670.98 nm (nm)
TLT $ 92.00 nm (nm)
GLD $ 379.66 $ -25.91 (-6.43 %)
$ 2.88
$ 2.94
$ 2.89 x 25
$ 3.02 x 50
$ 2.86 - $ 3.09
$ 2.80 - $ 283.40
362,523
na
na
$ 1.33
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION